Previous Article | Next Article ![]()
Journal of Virology, June 2000, p. 5470-5476, Vol. 74, No. 12
Unité des Virus Lents, CNRS URA
1930,1 and Unité d'Immunité
Cellulaire Antivirale,2 Institut Pasteur,
75724 Paris Cedex 15, France
Received 8 November 1999/Accepted 20 March 2000
H-2b mice are resistant to persistent
infection of the central nervous system by Theiler's virus. They clear
the infection 7 to 10 days after intracranial inoculation. Resistance
maps to the H-2D gene and not to the H-2K gene
and is associated with a potent antiviral cytotoxic T-lymphocyte (CTL)
response. We used H-2b mice in which the
H-2D or the H-2K gene had been inactivated to
dissect the respective roles of these genes in resistance. We report
that H-2D The DA strain of Theiler's virus, a
picornavirus of mice, causes a persistent infection of the spinal cord
with primary demyelination which is one of the best models of multiple
sclerosis (19). The disease that follows intracranial
inoculation is biphasic. An acute gray matter encephalomyelitis, which
lasts 7 to 10 days, is followed by a low-grade persistent infection of
the white matter with chronic inflammation and primary demyelination.
The severity of clinical symptoms associated with persistent infection
depends on the central nervous system (CNS) viral load (2).
Susceptibility to viral persistence and the accompanying pathology
varies greatly between inbred strains of mice (7). Strains
which are resistant to persistent infection clear the infection after
the acute encephalomyelitis. Although susceptibility is multigenic, the
H-2D locus, but not the H-2K locus, has a major
effect as shown by studying H-2 congenic mice and the dm1
mutation, a large deletion which fuses the H-2D and
H-2L genes and which confers susceptibility to the resistant parental B10.D2 strain (9, 10, 28).
Because the H-2b resistant haplotype is dominant
over the susceptible H-2q haplotype (9,
25), direct evidence that the major histocompatibility complex
class I H-2D gene is responsible for susceptibility was obtained by showing that H-2q mice become
resistant to viral persistence and to demyelination when they are
transgenic for the H-2Db gene (3,
26). The role of the H-2Db gene is also
shown by the fact that mutations in the gene modify susceptibility to
demyelination (18). The generally held view is that the
H-2Db gene brings about resistance by efficient
viral epitope presentation resulting in viral clearance by cytotoxic T
lymphocytes (CTL) and prevention of demyelination (13, 19).
Several observations support the role of the CTL response in viral
clearance: CD8+ T cells invade the CNS at a later time in
susceptible SJL/J mice than in resistant C57BL/6 mice (16),
H-2b mice with an inactivated
The genome of H-2b mice contains two classical
H-2 class I genes, H-2D and H-2K,
which are located in different regions. Both class I molecules are
highly polymorphic and can present peptides efficiently. Yet, at least
for the H-2b, H-2d, and
H-2k haplotypes, resistance to Theiler's
virus-induced disease maps to the H-2D and not the
H-2K gene. This may suggest that, at least in the CNS, some
functions of the H-2D and H-2K molecules other than their capacity to
bind and present peptides are different in the course of viral
infections. Interestingly, H-2D molecules are expressed at a higher
level than H-2K molecules in the CNS of H-2s
SJL/J mice during the acute phase of Theiler's virus infection, a
difference which is not observed for H-2b mice
(1). On the other hand, H-2D-, but not
H-2K-, restricted CTL are found in the CNS of
H-2b mice at that time, whereas neither
H-2D- nor H-2K-restricted CTL are found in the
CNS of H-2s mice (15). In the present
work, we used H-2b mice in which the
H-2D or the H-2K gene had been inactivated by
homologous recombination to further dissect the respective roles of
these genes in the resistance to persistent infection by Theiler's virus.
Animals and virus.
H-2Db
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
H-2Db
/
Mice Are Susceptible to
Persistent Infection by Theiler's Virus



![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
but not
H-2K
/
mice were susceptible to persistent
infection. Furthermore, whereas H-2K
/
mice mounted a vigorous virus-specific CTL response, similar to that of
control C57BL/6 mice, the CTL response of
H-2D
/
mice was nil or minimal. Using target
cells transfected with the H-2Db or the
H-2Kb gene, we showed that the
H-2K-restricted CTL response against the virus was minimal
in H-2D
/
mice. These results demonstrate
that the H-2Db and
H-2Kb genes play nonredundant roles in the
resistance to this persistent infection.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
2-microglobulin gene become susceptible to viral
persistence and to demyelination (14, 24, 27), CD8+ T-cell depletion renders mice less efficient at
clearing the infection (5), and resistance can be conferred
on susceptible substrains of BALB/c mice by passive transfer of
CD8+ T cells isolated from resistant substrains
(20). H-2Db-restricted CTL have been
isolated from the spleen and CNS of resistant C57BL/6 mice (11,
17), and an immunodominant
H-2Db-restricted viral epitope has been
characterized elsewhere (6, 12). Interestingly, CTL activity
is detected very early after inoculation of resistant C57BL/6 mice and
rises sharply thereafter, whereas it appears late in susceptible SJL/J
mice and remains at a low level (11).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
and
H-2Kb
/
mice were bred at the Institut
Pasteur animal facility in specific-pathogen-free sanitary conditions.
C57BL/6 mice were purchased from Iffa Credo (Les Oncins, France) or
Janvier (Le Genest-St. Isle, France). The construction of the
H-2Db
/
and the
H-2Kb
/
mice has been described in detail
elsewhere (21, 23). C57BL/6 × 129/Sv mice heterozygous
for the mutations were successively backcrossed toward the C57BL/6 mice
and intercrossed to obtain homozygous null-mutant mice. The
H-2Db
/
mice were backcrossed for four or six
generations, depending on the experiment, and the
H-2Kb
/
mice were backcrossed for six generations.
Preparation of total RNA from brain or spinal cord and dot blot
hybridization.
Total RNA was extracted from brain or spinal cord
as described in detail elsewhere (9). Fivefold dilutions of
total RNA, starting from 10 µg, were immobilized on duplicate Hybond
C-Extra filters (Amersham Corp., Arlington Heights, Ill.) according to the manufacturer's recommendation. Filters were hybridized with 106 cpm of a random-primed 32P-labeled cDNA
probe specific for the virus or for
-actin overnight at 65°C in
0.5 M sodium phosphate (pH 7.4)-7% sodium dodecyl sulfate. The
filters were washed four times for 15 min at 65°C in 40 mM sodium
phosphate (pH 7.4)-1% sodium dodecyl sulfate, dried, exposed overnight, and analyzed with a phosphorimager (Becton Dickinson). Hybridization to the
-actin probe was used to control the quality of
the RNA samples. The highest dilution which gave a positive signal with
the virus-specific probe was used as a measure of viral RNA content. To
normalize the results of different experiments, dilutions of RNA
samples previously analyzed were run as standards on the filters.
Immunohistochemistry. The mice were anesthetized with ether, perfused through the left ventricle with 20 ml of PBS followed by 20 ml of 4% paraformaldehyde in PBS. The brain and spinal cord were dissected out, refixed by immersion, and embedded in paraffin using routine procedures. Serial coronal sections of the brain and longitudinal sections of the spinal cord were prepared. The sections were reacted with a rabbit hyperimmune serum against Theiler's virus capsid proteins, followed by a biotinylated anti-rabbit secondary antibody and an avidin-biotin-horseradish peroxidase complex (Vectastain; Vector Laboratories, Burlingame, Calif.). The slides were developed with 0.01% H2O2-diaminobenzidine-tetrahydrochloride (DAB; Sigma) in 0.05 Tris-HCl (pH 7.5) for 5 min and counterstained with Harris hematoxylin.
CTL assay.
The generation of CTL, the 51Cr
labeling and preparation of target cells, and the CTL assay have been
described in detail elsewhere (12). Briefly, mice were
inoculated intraperitoneally with 106 PFU of Theiler's
virus, and splenocytes were prepared 3 weeks later. Splenocytes were
restimulated in vitro for 5 days by cocultivation with Theiler's
virus-infected, irradiated, syngeneic splenocytes. Three kinds of
target cells were used: C57SV (H-2b) fibroblasts
and Ltk
cells stably transfected with either the
H-2Db or the H-2Kb gene.
Target cells were obtained by loading them with 51Cr
followed by infection with Theiler's virus for 2 h. Cytolytic activity of restimulated splenocytes was measured by a standard 51Cr release assay.
Statistical analysis. The means of the scores of viral persistence were compared among mouse strains using either the unpaired Student t test or the analysis of variance and its associated Scheffe test from the Statview F-4.5 package.
| |
RESULTS |
|---|
|
|
|---|
H-2Db
/
, but not
H-2Kb
/
, mutant mice are susceptible to
persistent infection and to late white matter disease.
H-2b mice are resistant to persistent infection
by Theiler's virus. Because
H-2b
2m
/
mutant mice are
susceptible (14, 24, 27), it has been assumed that
H-2b-associated resistance was due to a class
I-restricted CTL response. We tested the role of class I genes in
resistance directly by examining the phenotype of mice in which the
H-2Db or the H-2Kb gene
had been inactivated by homologous recombination (21, 23).
H-2Db
/
mice were obtained from C57BL/6 × 129/Sv H-2Db+/
mice after backcrossing
toward the C57BL/6 background for four or six generations, depending on
the experiment, followed by intercrossing to obtain homozygous mutants.
The H-2Kb
/
mutant mice were obtained in a
similar way after backcrossing toward the C57BL/6 inbred strain for six
generations. The mutant mice, as well as control C57BL/6 mice, were
inoculated with 104 PFU of Theiler's virus, strain DA, and
sacrificed 45 days later. Neither mutants nor controls showed clinical
symptoms. Their spinal cords were examined for viral RNA levels and
histopathology, as described in Materials and Methods. The results of
the experiment are shown in Table 1.
|
/
mice than in the case of C57BL/6 mice
(mDb
/
= 1.3 ± 0.3 [n = 14], mC57BL/6 = 0.0 ± 0.0 [n = 11], P = 0.0034) and of H-2Kb
/
mice (mKb
/
= 0.0 ± 0.0 [n = 6], P = 0.0164). The variation in RNA level
between individual H-2Db
/
mice might have
been due to the fact that the animals were obtained after only four to
six backcrosses toward the C57BL/6 strain. The level of viral RNA was
also examined 90 days postinfection (p.i.) in the spinal cord of
H-2Db
/
mice (Table 1). The level was higher
than at 45 days p.i. (mDb
/
= 2.5 ± 0.0 [n = 7]), and there was less variation from
mouse to mouse. This result confirmed that the DA strain of Theiler's virus persists in the CNS of H-2Db
/
mice.
Using immunohistochemistry, infected cells were observed in the white
matter of the spinal cord of 10 out of 15 H-2Db
/
mice examined at 45 days p.i.
Infected cells were accompanied by meningitis, perivascular cuffs, and
diffuse parenchymal inflammation (Fig.
1). At the same time p.i., a small number
of antigen-containing cells
fewer than 10 cells per longitudinal
section of the entire spinal cord
was observed in the spinal cord of
only two out of six H-2Kb
/
mice examined,
exclusively in the gray matter (data not shown).
|
/
mice were susceptible to persistent
infection of the white matter and to chronic inflammation, whereas
H-2Kb
/
mice and, as expected, C57BL/6
control mice were resistant.
Viral replication and histopathology in the CNS of
H-2Db
/
mice at early times after
inoculation.
Resistant C57BL/6 mice clear the infection at the end
of the early, gray matter, encephalomyelitis, whereas
H-2Db
/
mice remain persistently infected. To
compare the patterns of CNS infection in both mouse strains at the time
when virus is cleared in the C57BL/6 strain,
H-2Db
/
mutant mice and wild-type C57BL/6
mice were inoculated with 104 PFU of Theiler's virus,
strain DA, and sacrificed 6 and 21 days later. Levels of viral RNA and
histopathology were examined in brain and spinal cord. The results are
shown in Table 1. At the peak of the early phase of the disease (6 days
p.i.), the levels of viral RNA were not significantly different in the
brain of control and H-2Db
/
mice
(mC57BL/6 = 0.17 ± 0.17 [n = 3], mDb
/
= 0.25 ± 0.25 [n = 6]). On the other hand, a significant amount of
viral RNA was already detected at this time in the spinal cord of
H-2Db
/
mice, whereas no viral RNA could be
found in the spinal cord of C57BL/6 mice (mC57BL/6 = 0.00 ± 0.00 [n = 3],
mDb
/
= 0.67 ± 0.31 [n = 6]). Histopathological examination showed many cells containing viral antigens in the gray matter of the brain of five
out of six wild-type mice and six out of eight mutant mice examined.
Infected cells were located mainly along the needle track but also in
scattered cortical and subcortical foci as well as in the hippocampus
in some of the mice, regardless of the genotype (data not shown).
/
mice examined
(mDb
/
= 0.86 ± 0.32 [n = 7]). Large numbers of viral antigen-containing
cells and severe inflammation were observed in the white matter of
spinal cord of five out of six H-2Db
/
mice
examined (Fig. 2B). Intense meningitis was also present. Although
inflammatory foci were present in the gray matter, only a few infected
cells were observed in this compartment. One of the six
H-2Db
/
mice examined had lesions that were
less extensive, but otherwise similar.
|
/
null mutation does
not affect the pattern of the early disease in brain. As for
susceptible mice, the establishment of viral persistence coincides with
the localization of the infection to the white matter of spinal cord
(2, 4).
Anti-Theiler's virus CTL activity in null-mutant and control
mice.
Resistant C57BL/6 mice develop a fast and intense
H-2Db-restricted CTL response directed at an
immunodominant epitope and only a weak
H-2Kb-restricted response (11). The
fact that H-2Db
/
mice become susceptible and
that H-2Kb
/
mice remain resistant is
consistent with the role of H-2Db-restricted CTL
in resistance and suggests that H-2Kb-restricted
CTL are unable to clear the infection. To examine these points further,
we studied the virus-specific H-2Db- and
H-2Kb-restricted CTL responses of
H-2Db
/
mice. Briefly, 6- to 8-week-old
H-2Db
/
and control C57BL/6 mice were
inoculated intraperitoneally with 106 PFU of Theiler's
virus. Spleen cells were prepared from individual mice 9 days later and
restimulated in vitro with syngeneic infected splenocytes. Restimulated
splenocytes were tested, in a 51Cr release assay, against
infected C57SV fibroblasts or infected L cells expressing the
H-2Db or the H-2Kb molecule. Figure
3 shows the results for one control
C57BL/6 mouse and four individual H-2Db
/
mice. As shown by the figure, the splenocytes of
H-2Db
/
mice had a much lower cytolytic
activity against infected C57SV fibroblasts than did those of control
C57BL/6 mice. However, a low but significant cytolytic activity was
observed, for all four H-2Db
/
mice, at
effector-to-target ratios of 60:1. In one case, mouse number 4, the
activity was detected even at low effector-to-target ratios. Figure
4A shows that no
H-2Db-restricted cytolytic activity was detected
in H-2Db
/
mice, whereas splenocytes from
C57BL/6 mice could lyse infected L cells expressing the
H-2Db molecule. On the other hand, low but measurable
cytolytic activity was observed in H-2Db
/
mice against L cells expressing the H-2Kb molecule
(Fig. 4B). This activity probably explains the cytolytic activity
of splenocytes from H-2Db
/
mice against
infected C57SV fibroblasts (Fig. 3). Lastly, the splenocytes of
infected H-2Kb
/
mice lysed infected C57SV
fibroblasts as efficiently as did splenocytes of control C57BL/6 mice
(Fig. 5). In summary, these results
confirm that the majority of the CTL activity of C57BL/6 mice
against Theiler's virus is H-2Db restricted.
Inactivating the H-2Db gene causes only a slight
increase in the H-2Kb-restricted response, which
is insufficient to prevent persistence of the infection.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The resistance of H-2b mice to persistent
infection by Theiler's virus maps to the H-2Db
locus and not to the H-2Kb locus.
Interestingly, only H-2D-restricted virus-specific CTL are
found in the CNS of resistant C57BL/10 mice at the time of viral
clearance, although both H-2D- and
H-2K-restricted CTL are found in spleen (17). The
results presented in this article show that inactivating the
H-2Db, but not the H-2Kb,
gene makes the animal susceptible to persistent infection. Therefore, they confirm the unique properties of the H-2Db
gene in this system. This uniqueness is puzzling since both the H-2D and the H-2K genes code for class I
molecules with similar potentials for peptide presentation. It could be
explained in at least two ways. Since class I genes are not expressed
in healthy CNS tissue, it is possible that the expression of the H-2D
and H-2K molecules in CNS is regulated differently upon infection by
Theiler's virus. This hypothesis is not upheld by the results of
Altintas et al., who observed the same transient increase of expression
for both class I molecules after intracranial inoculation of C57BL/6
mice with Theiler's virus (1). Another possibility is that
the viral immunodominant H-2Db-restricted
epitope (6, 12) is much more efficient at eliciting an
immune response than are viral H-2Kb-restricted
epitopes. This hypothesis is supported by recent data showing that the
exons coding for the
1 and
2 domains of the H-2Db
molecule, domains which bind the peptide epitope, are responsible for
resistance (A. Azoulay-Cayla et al., unpublished data). The unique role
played by the H-2D gene in Theiler's virus infection has
been demonstrated for the b haplotype. At present, we do not know if it exists also for other haplotypes.
The SJL/J strain is the prototypic strain susceptible to the
persistence of Theiler's virus. Although we did not compare the H-2Db
/
and SJL/J strains in the same
experiment, the level of viral RNA in the former, 45 days p.i., was
lower, and there was more variation between individuals, than what we
routinely observe in the latter. This difference might be due to the
existence of several susceptibility loci which are found in only the
SJL/J strain (8). It is interesting that, by 90 days p.i.,
the level of viral RNA in H-2Db
/
mice
becomes similar to that observed in SJL/J mice 45 days p.i.
The results presented in this article demonstrate that the
H-2Db gene is required for clearance of
Theiler's virus, whereas the H-2Kb gene is not.
There is strong evidence in the literature that H-2b mice clear Theiler's virus infection
through a vigorous H-2Db-restricted CTL response
(6, 11, 12, 15). The fact that, in the experiments reported
here, resistance is associated with such a virus-specific CTL response
supports this conclusion. However, it has not been determined if these
CTL target infected gray matter neurons or white matter glial cells as
they become infected at the end of the early encephalomyelitis. The
fact that the early neuronal infection was of the same magnitude in
C57BL/6 mice and in H-2Db
/
mice suggests
that the CTL do not clear the infection from infected neurons. The fact
that H-2Db
/
mice do not mount a significant
antiviral CTL response and are susceptible to persistent infection
suggests very strongly that CTL are critical for viral clearance in
wild-type mice. We cannot formally exclude a role of the
H-2Db gene in the virus-specific CD4 and
antibody responses, especially since it has been shown that circulating
antibodies contribute to the resistance of the C57BL/6 strain (22,
29).
As shown in this article, H-2Db
/
mice were
unable to mount an efficient, compensatory
H-2Kb-restricted CTL response. This is shown by
the susceptibility to persistent infection of the
H-2Db
/
mice and, more directly, by the low
specific cytotoxicity of splenocytes of infected
H-2Db
/
mice against
H-2Kb-expressing target cells (Fig. 4B). This result is in
striking contrast with that obtained when the same mutant mice were
infected with lymphocytic choriomeningitis virus. In this case,
H-2Db
/
mice developed a normally subdominant
H-2Kb-restricted CTL response which resulted in
fatal choriomeningitis (23). This difference in behavior of
the same mouse strain when infected by two different viruses emphasizes
the danger of generalizing results for the immune responses to viral infections.
| |
ACKNOWLEDGMENTS |
|---|
We thank Sylvie Syan for excellent technical assistance and Mireille Gau for secretarial help.
Arièle Azoulay-Cayla was supported by fellowships from the Association pour la Recherche sur la Sclérose en Plaques and the Fondation pour la Recherche Médicale. Research on Theiler's virus in the Unité des Virus Lents is supported by grants from Institut Pasteur, CNRS, the Association pour la Recherche sur la Sclérose en Plaques, and the National Multiple Sclerosis Society, United States.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Unité des Virus Lents, CNRS URA 1930, Institut Pasteur, 28, rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: 33(0)1 45 68 87 70. Fax: 33(0)1 40 61 31 67. E-mail: mbrahic{at}pasteur.fr.
Present address: Fédération de Neurologie,
Hôpital de la Pitié-Salpêtrière, 75651 Paris
Cedex 13, France.
Present address: McKinsey & Company, Inc., 80538 Munich, Germany.
§ Present address: Department of Immunology, Division of Investigative Science, ICSM Chelsea & Westminster Hospital, London SW10 9NH, United Kingdom.
Present address: Centre d'Immunologie de Marseille-Luminy, 13288 Marseille Cedex 9, France.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altintas, A., Z. Cai, L. R. Pease, and M. Rodriguez. 1993. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J. Immunol. 151:2803-2812[Abstract]. |
| 2. |
Aubagnac, S.,
M. Brahic, and J.-F. Bureau.
1999.
Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus.
J. Virol.
73:7965-7971 |
| 3. |
Azoulay, A.,
M. Brahic, and J.-F. Bureau.
1994.
FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.
J. Virol.
68:4049-4052 |
| 4. | Bihl, F., C. Pena-Rossi, J.-L. Guénet, M. Brahic, and J.-F. Bureau. 1997. The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J. Virol. 71:5025-5030[Abstract]. |
| 5. |
Borrow, P.,
P. Tonks,
C. J. R. Welsh, and A. A. Nash.
1992.
The role of CD8+ T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice.
J. Gen. Virol.
73:1861-1865 |
| 6. | Borson, N. D., C. Paul, X. Lin, W. K. Nevala, M. A. Strausbauch, M. Rodriguez, and P. J. Wettstein. 1997. Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71:5244-5250[Abstract]. |
| 7. | Brahic, M., and J.-F. Bureau. 1998. Genetics of susceptibility to Theiler's virus infection. Bioessays 20:627-633[CrossRef][Medline]. |
| 8. | Bureau, J.-F., X. Montagutelli, F. Bihl, S. Lefebvre, J.-L. Guénet, and M. Brahic. 1993. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:87-91[CrossRef][Medline]. |
| 9. |
Bureau, J.-F.,
X. Montagutelli,
S. Lefebvre,
J.-L. Guénet,
M. Pla, and M. Brahic.
1992.
The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.
J. Virol.
66:4698-4704 |
| 10. | Clatch, R. J., R. W. Melvold, S. D. Miller, and H. L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV) induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV specific delayed-type hypersensitivity. J. Immunol. 135:1408-1413[Abstract]. |
| 11. | Dethlefs, S., M. Brahic, and E. L. Larsson-Sciard. 1997. An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. J. Virol. 71:8875-8878[Abstract]. |
| 12. | Dethlefs, S., N. Escriou, M. Brahic, S. van der Werf, and E.-L. Larsson-Sciard. 1997. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J. Virol. 71:5361-5365[Abstract]. |
| 13. | Drescher, K. M., L. R. Pease, and M. Rodriguez. 1997. Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol. Rev. 159:177-193[CrossRef][Medline]. |
| 14. |
Fiette, L.,
C. Aubert,
M. Brahic, and C. Pena Rossi.
1993.
Theiler's virus infection of 2-microglobulin-deficient mice.
J. Virol.
67:589-592 |
| 15. | Lin, X., L. R. Pease, and M. Rodriguez. 1997. Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur. J. Immunol. 27:963-970[Medline]. |
| 16. | Lindsley, M. D., and M. Rodriguez. 1989. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142:2677-2682[Abstract]. |
| 17. |
Lindsley, M. D.,
R. Thiemann, and M. Rodriguez.
1991.
Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.
J. Virol.
65:6612-6620 |
| 18. | Lipton, H. L., R. Melvold, S. D. Miller, and M. C. Dal Canto. 1995. Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. J. Neurovirol. 1:138-144[Medline]. |
| 19. | Monteyne, P., J.-F. Bureau, and M. Brahic. 1997. The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 159:163-176[CrossRef][Medline]. |
| 20. | Nicholson, S. M., M. C. Dal Canto, S. D. Miller, and R. W. Melvold. 1996. Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J. Immunol. 156:1276-1283[Abstract]. |
| 21. |
Pascolo, S.,
N. Bervas,
J. M. Ure,
A. G. Smith,
F. A. Lemonnier, and B. Pérarnau.
1997.
HLA-A2.1-restricted education and cytolytic activity of CD8 (+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice.
J. Exp. Med.
185:2043-2051 |
| 22. |
Pena Rossi, C.,
E. Cash,
C. Aubert, and A. Coutinho.
1991.
Role of the humoral immune response in resistance to Theiler's virus infection.
J. Virol.
65:3895-3899 |
| 23. | Pérarnau, B., M. F. Saron, B. R. San Martin, N. Bervas, H. Ong, M. J. Soloski, A. G. Smith, J. M. Ure, J. E. Gairin, and F. A. Lemonnier. 1999. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29:1243-1252[CrossRef][Medline]. |
| 24. | Pullen, L. C., S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1993. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287-2293[Medline]. |
| 25. | Rodriguez, M., and C. S. David. 1985. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:2145-2148[Abstract]. |
| 26. | Rodriguez, M., and C. S. David. 1995. H-2Dd transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1:111-117[Medline]. |
| 27. |
Rodriguez, M.,
A. J. Dunkel,
R. L. Thiemann,
J. Leibowitz,
M. Zijlstra, and R. Jaenisch.
1993.
Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in 2-microglobulin.
J. Immunol.
151:255-276.
|
| 28. |
Rodriguez, M.,
J. L. Leibowitz, and C. S. David.
1986.
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.
J. Exp. Med.
163:620-631 |
| 29. | Rodriguez, M., A. K. Patick, and L. R. Pease. 1990. Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. J. Neuroimmunol. 26:189-199[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»